Our Investments
We believe in nurturing ideas and building companies. From inception to exit, we want to work with you and help you succeed in your entrepreneurial journey
Portfolio Companies
Auricle Inc
Dr. Francis Wong, Jay Dhuldhoya, Dr. Santa Maria
Auricle is a medical device company developing a breakthrough neurostimulation implant to restore hearing in the millions of patients who no longer benefit from hearing aids and are not served by existing solutions. The company was born out of Stanford Biodesign and is proud to be supported by Y Combinator, StartX and Fogarty Innovation.
Certus Critical Care
Austin Johnson, MD, PhD; Timothy Williams, MD; Lucas Neff, MD; Jason Adams, MD
Our mission is to increase survival and quality of life in the aftermath of stroke, cardiac arrest, and hemorrhagic shock with an adaptive and intelligent endovascular balloon catheter. Certus Critical Care has designed the EVAC System as a next-generation endovascular technology for precision control of hemodynamics in patients with stroke, cardiac arrest, or uncontrolled hemorrhage. EVAC automates partial aortic occlusion to optimize patient hemodynamics. Improved outcomes are supported by >250 large animal studies.
Cohere Med
Srikanth Muthya, Renjith Nair, Ajit Thomas
The world’s first platform that harnesses high-fidelity patient data to reveal actionable foresight
Geneyx Inc
David Yizhar, Dvir Dahary, Raviv Itzhaky and Ofer Barnea
FROM ANALYSIS TO DISCOVERY - Driving the Future of Clinical Genetic Data Analysis. Geneyx offers best-in-class practices harnessing genetic data available to guide digital insights for rare and germline disorders and diseases. We aim to enrich disease-specific, clinically relevant insights around risk prediction, diagnosis, prognosis, and treatment for clinical and pharmaceutical organizations. Our AI-based platform is the first and best choice for hospitals, genetic labs, translational, and early target discovery researchers at Pharma and BioTech. Geneyx proprietary platform doubles the diagnostic yield while taking turn-around time from hours to minutes. Geneyx’s technology provides biomedical interpretation capabilities for the largest scope of the human genome. We continually provide new solutions for enhancing this scope. This enables researchers to better leverage the power of whole-genome sequencing data. The novel findings they can distill because of this technology will lead to the development of the next generation of targeted and personalized therapeutics and diagnostics.
SIAMAF Healthcare
Dr. Subhasis Sarangi
SIAMAF Healthcare is a cancer theranostics company developing magnetic nanotechnology for radiation-free and affordable cancer diagnosis and therapy. Bringing innovative solutions for cancer staging, screening, localization, imaging, and hyperthermia. We are a team of scientists, engineers, and clinicians with significant global research and industry experience in nanotechnology and biotechnology. We are committed to solve some of the challenging healthcare problems through innovative, practical, and cutting-edge technology solutions.
Stasis Labs
Michael Maylahn, Dinesh Seemakurty
Stasis provides a FDA cleared remote monitoring solution for patient care in facilities and at home. Stasis has an end-to-end solution that collects vitals data from the bedside, and flexibly centralizes the monitoring information to provide remote access to physicians and clinical teams wherever is most convenient for them. Through automated data collection, remote connectivity, and predictive alerts - we help our clients increase patient safety while improving their profitability. As of June 2021, we’ve provided care for over 50,000 patients.
Stasys Medical Corp
Robert Barry, Nate Sniadecki, Nathan White
Stasys Platelet system is designed to form microclots from whole blood samples to measure platelet forces, aggregation, and function. No use of agonists or reagents, no offsite labs; faster, more accurate results means faster, more informed decision-making for trauma doctors.
Veriskin Inc.
Dr. Mirianas Chachisvilis, Dr. Carl Edman, Eugene Tu
Veriskin, Inc., headquartered in San Diego, California, is developing a new method and device for non-invasive diagnostics for skin cancer. Skin cancer is the most common form of cancer in the world, accounting for >5 million diagnoses in the US alone. Unfortunately, skin cancers are very difficult to diagnose and distinguish from non-cancerous skin abnormalities. Overall, the lack of accurate, objective assessment tool for dermatologists and non-expert clinicians leads to preventable loss of 120,000+ lives and avoidable costs (in the US over $3B each year). TruScore is a proprietary, non-invasive, low-cost, hand-held device that aids a non-expert user to rapidly and objectively determine whether a suspect skin lesion is cancerous. The patented, non-imaging based technology works by detecting both structural and functional vascular abnormalities associated with pathological angiogenesis which is a well-established, early marker of cancer. VeriSkin has developed a proprietary AI algorithm and protocols to achieve unparalleled screening accuracy in differentiating clinically significant skin cancers from a variety of benign conditions.
Zeit Medical
Orestis Vardoulis, Urs Naber, MD
Zeit Medical is a telehealth company that offers at-home monitoring and alerts for individuals who live with the risk of stroke. At-risk individuals struggle with a daily fear that a stroke might happen during night time or when they are alone and go unnoticed for hours before help arrives. To alleviate that fear, Zeit Medical offers a smart headband that analyzes EEG waveforms to detect the onset of an event immediately and alert the patient, caregivers, and 911. Each year, more than 10 million Americans struggle with the idea of having a stroke. Zeit Medical will provide peace of mind as a service for these individuals.